Further Thoughts on Abnormal Chromatin Configuration and Oncogenesis
More than 30 years ago, we published a paper entitled as abnormal chromatin configuration and oncogenesis, which proposed the first hypothesis that links oncogenesis to abnormal three-dimensional (3D) genome structure. Recently, many studies have demonstrated that the 3D genome structure plays a major role in oncogenesis, which strongly supports our hypothesis. In this paper, further thoughts about our hypothesis is presented.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Evidence of epigenetic oncogenesis: a turning point in cancer research
In cancer research, the term epigenetics was used in the 1970s in its modern sense encompassing non-genetic events modifying the chromatin state, mainly to oppose the emerging oncogene paradigm. However, starting from th…
Chromatin Laser Imaging Reveals Abnormal Nuclear Changes for Early Cancer Detection
We developed and applied rapid scanning laser-emission microscopy to detect abnormal changes in cell nuclei for early diagnosis of cancer and cancer precursors. Regulation of chromatins is essential for genetic developme…
Flexible Cancer-Associated Chromatin Configuration (CACC) Might Be the Fundamental Reason Why Cancer Is So Difficult to Cure
We once proposed that cell-type-associated chromatin configurations determine cell types and that cancer cell type is determined by cancer-associated chromatin configuration (CACC). In this paper, we hypothesize that fle…
Vocal Bursts Type PredictionHow human-derived brain organoids are built differently from brain organoids derived from genetically-close relatives: A multi-scale hypothesis
How genes affect tissue scale organization remains a longstanding biological puzzle. As experimental efforts aim to quantify gene expression, chromatin organization, cellular structure, and tissue structure, computationa…
Identifying Key Genes in Cancer Networks Using Persistent Homology
Identifying driver genes is crucial for understanding oncogenesis and developing targeted cancer therapies. Driver discovery methods using protein or pathway networks rely on traditional network science measures, focusin…